The Madurai Hypoglycaemia Survey a snapshot of hypoglycaemic (un)awareness in India

Authors

  • Krishnan Swaminathan Department of Endocrinology, Kovai Medical Center & Hospital, India

DOI:

https://doi.org/10.15277/bjdvd.2014.037

Abstract

Aim: To assess prescribing practices and patient awareness of issues relating to hypoglycaemia in a South Indian population.

Methods: A standard questionnaire was administered to one hundred consecutive patients with diabetes attending the Diabetes Clinic at Apollo Specialty Hospital, Madurai, India. All data were tabulated and analysed using Microsoft Excel 2007.

Results: There was a predominance of sulphonylurea use, in combination with oral agents and insulin. Nearly 60% of patients reported that their doctor never talked about hypoglycaemia during clinic visits. At least 20% of patients had at least one hospital admission related to a hypoglycaemic event since the diagnosis of diabetes. More than a third of patients were not aware of symptoms of hypoglycaemia nor did they know how to manage the symptoms.

Conclusions: Medical professionals in India need to do more to educate patients about issues relating to hypoglycaemia, its importance, awareness and appropriate management.

References

Rombopoulos G, Hatzikou M, Latsou D, et al. The prevalence of Hypoglycaemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study). Hormones (Athens) 2013;12:550-8. http://dx.doi.org/10.14310/horm.2002.1443

Zoungas S, Patel A, Chalmers J, et al; ADVANCE Collaborative Group. Severe Hypoglycaemia and risks of vascular events and death. N Engl J Med 2010;363:1410-8. http://dx.doi.org/10.1056/NEJMoa1003795

Kosiborod M, Inzucchi SE, Goyal A, et al. Relationship between spontaneous and iatrogenic hypoglycaemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009;301:1556-64. http://dx.doi.org/10.1001/jama.2009.496

Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care 2013;17(2):R52

Svensson AM, McGuire DK, Abrahamsson P, et al. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005;26:1255-61. http://dx.doi.org/10.1093/eurheartj/ehi230

Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008;24:353-63. http://dx.doi.org/10.1002/dmrr.865

Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010; 340:b4909. http://dx.doi.org/10.1136/bmj.b4909

Goto A, Arah OA, Goto M, et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013;347:f4533. http://dx.doi.org/10.1136/bmj.f4533

Heller SR, Choudhary P, Davies C, et al. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7. http://dx.doi.org/10.1007/s00125-007-0599-y

Kalra S, Deepak MC, Narang P, et al. Usage pattern, glycaemic improvement, hypoglycaemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE Hypoglycaemia Study. Diabetes Technol Ther 2013;15:129-35. http://dx.doi.org/10.1089/dia.2012.0237

Al-Arouj M, Hassoun AA, Medlej R, et al. The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study. Int J Clin Pract 2013;67:957-63.

Aravind SR, Ismail SB, Balamurugan R, et al. Hypoglycaemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin 2012;2:1289-96. http://dx.doi.org/10.1185/03007995.2012.707119

Swinnen SG, Dain MP, Mauricio D, et al. Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes. Diabetes Obes Metab 2010;12:923-5. http://dx.doi.org/10.1111/j.1463-1326.2010.01258.x

Willis WD, Diago-Cabezudo JI, Madec-Hily A, et al. Medical resource use, disturbance of daily life and burden of hypoglycaemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res 2013;13:123-30. http://dx.doi.org/10.1586/erp.12.80

Downloads

Published

2015-02-09

Issue

Section

Learning from practice